Dose effect relationship of oxyepinephrine in the prevention of hypotension during cesarean section and oxytocin in the treatment of uterine atony

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2200059556

Enrollment

Unknown

Registered

2022-05-04

Start date

2022-05-01

Completion date

Unknown

Last updated

2024-03-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Group 1:Oxytocin 2.5 U

Group 2:Oxytocin 5 U

Group 3:Oxytocin 7.5 U

Group 4:Oxytocin 10U

Eligibility

Sex/Gender

Female

Age

18 Years to 40 Years

Inclusion criteria

Inclusion criteria: ASA statue of I or II, patients with a single pregnancy, at full-term (gestational aged >= 37 weeks).

Exclusion criteria

Exclusion criteria: 1. Diabetes mellitus or gestational diabetes mellitus, hypertension or preeclampsia; 2. Fetus with intrauterine growth restriction or giant, placenta previa, placenta adhesion, placenta accreta, and major maternal diseases; 3. Absolute contraindications to spinal or epidural anesthesia, such as local infection or bleeding disorders.

Design outcomes

Primary

Measure	Time frame
Success rate of treating uterine atony;	—

Secondary

Measure	Time frame
Incidence of hypotension;Anesthesia block plane;	—

Countries

China

Contacts

Public ContactShen Yaohua

13989852772@163.com+86 13989852772

Outcome results